Apobiologix
2400 North Commerce Parkway
Suite 300
Weston
Florida
33326
United States
Tel: 855-276-7744
Website: http://www.apobiologix.com/
About Apobiologix
Apobiologix, a part of the Apotex group focused on biologics innovation, is a pioneer in the field of biosimilars. The company has a robust pipeline of biologic products, and aims at providing patients and providers with healthcare products that offer high quality and value.LEADERSHIP:
President: Steve Lydeamore
JOBS:
Please click here for Apobiologix job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
6 articles about Apobiologix
-
PRE-FILLED AUTOINJECTOR OFFERS INNOVATIVE OPTION TO CANADIAN CANCER PATIENTS
11/28/2022
Apobiologix, a division of Apotex Inc., expanded its product portfolio with the launch of a pre-filled autoinjector for Lapelga®, the company's biosimilar pegfilgrastim that launched in Canada in 2019.
-
Patient access to cost-effective treatments increased with launch of new biosimilar in Canada
2/28/2019
First-ever Pegfilgrastim Biosimilar Approved by Health Canada Launches Across the Country
-
Apotex Builds Momentum in Canada's Biosimilar Market After World's First Approval
6/1/2018
Apobiologix, a division of Apotex Inc., further bolstered its leadership in Canada's growing biosimilar market.
-
Apobiologix Applauds Supreme Court Decision In Sandoz Biosimilar Case
6/13/2017
-
Meridian Laboratories And Apobiologix Enter Into A Definitive Agreement For Development Of Docetaxel Injection
2/2/2017
-
Apobiologix Announces Victory Over Amgen In Biosimilar Patent Case
9/9/2016